http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-101744-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf2bd70463925dea0c24d82d82973bc5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f8278196a9bb0b305b30b4c058f9045 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-075 |
| filingDate | 2011-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_351a6eba06faeaa9e03ce1b76fe9b3b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c79402d0f2e490be22a70a4b79b2d6a8 |
| publicationDate | 2013-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-101744-C2 |
| titleOfInvention | FERTILIZATION METHOD IN VITRO |
| abstract | The invention relates to the field of embryology and medicine, namely gynecology and reproduction, and can be used in extracorporeal fertilization (IVF) programs, mainly in women with low ovulatory reserve and older age group, and to improve the quality of oocytes, reducing the number of injected drugs and drugs their negative impact to stimulate women in programs of ART (assisted reproductive technologies), the possibility of obtaining pregnancy from their own genetic material, without using donor oocytes in women with debilitated ovary syndrome and sharply reduced ovarian reserve. According to the method of in vitro fertilization in humans pre-selection of immature oocytes, introduce oocytes in vitro in the composition for cultivation, cultivate oocytes in the composition, fertilize the cultured oocytes by ICSI, cultivate embryos in the composition and embryo transplant -control when reaching their size 18- on the 14-15th day of the cycle, after the pre-administration of the trigger dose of chorionic gonadotropin, immature oocytes are selected at the stage of GV and / or M1, introducing in the in vitro conditions in a composition for cultivation containing at least D-glucose, disodium salt, gentamicin, glycine, calcium lactate, L-alanine, L-aspartic acid, L-asparagine monohydrate, L-glutamic acid, L-glutamine , L-Proline, L-serine, L-taurine, magnesium sulfate, potassium dihydroortophosphate, add human albumin in the amount of 10-20 mg / ml and grow in the process of cultivation to the mature stage of M2 within 24-40 hours. embryology and copper |
| priorityDate | 2011-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.